Literature DB >> 18618182

Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors.

Eren Berber1, Allan Siperstein.   

Abstract

BACKGROUND: The best measure of the technical success of radiofrequency ablation (RFA) is local recurrence (LR). The aim of this prospective study is to identify factors that predict LR.
METHODS: Three hundred thirty-five patients with 1032 unresectable liver tumors underwent laparoscopic RFA between November 1999 and August 2005. All lesions were assessed prospectively regarding tumor type, size, liver segment, blood vessel proximity, and central or peripheral location in the operating room and size of ablation zone at 1-week computed tomographic (CT) scans. Lesions that recurred in follow-up CT scans were identified prospectively. LR was categorized as contiguous or adjacent. Univariate Kaplan-Meier and Cox proportional hazard models were used for statistical analysis.
RESULTS: LR was identified 21.7% of tumors on CT scans with a mean follow-up of 17 months (median, 12 months; range, 3-68 months). This was contiguous in 70% and adjacent in 30%. LR rate per tumor was highest for colorectal metastasis (34%), followed by noncolorectal, nonneuroendocrine metastasis (22%), hepatocellular carcinoma (18%), and neuroendocrine metastasis (6%). By univariate analysis, tumor type and size, ablation margin, liver segmental location, blood vessel proximity, and type of ablation (first time vs. repeat) were found to affect LR. The Cox proportional hazard model identified tumor type, tumor size, ablation margin, and blood vessel proximity to be independent predictors of LR.
CONCLUSION: LR after RFA is predicted by certain tumor characteristics and technical factors. This information can be used intraoperatively to identify those tumors at a higher risk for failure.

Entities:  

Mesh:

Year:  2008        PMID: 18618182     DOI: 10.1245/s10434-008-0043-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  49 in total

1.  The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Yasue Niwa; Masayuki Mima; Osamu Fujii; Ryohei Sasaki; Isamu Yamada; Yuichi Hori; Yoshio Hishikawa; Mitsuyuki Abe; Yonson Ku; Masao Murakami
Journal:  J Gastroenterol       Date:  2011-04-23       Impact factor: 7.527

Review 2.  [Interventional procedures for hepatic metastases].

Authors:  T Helmberger
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

3.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

4.  Two-stage treatment with hepatectomy and carbon-ion radiotherapy for multiple hepatic epithelioid hemangioendotheliomas.

Authors:  Shohei Komatsu; Takeshi Iwasaki; Yusuke Demizu; Kazuki Terashima; Osamu Fujii; Atsushi Takebe; Akihiro Toyokawa; Kazuhiro Teramura; Takumi Fukumoto; Yonson Ku; Nobukazu Fuwa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factor.

Authors:  Geoffrey Ledoux; Koceila Amroun; Rami Rhaiem; Audrey Cagniet; Arman Aghaei; Olivier Bouche; Christine Hoeffel; Daniele Sommacale; Tullio Piardi; Reza Kianmanesh
Journal:  Surg Endosc       Date:  2020-02-19       Impact factor: 4.584

Review 6.  The Landmark Series: Neuroendocrine Tumor Liver Metastases.

Authors:  Alexandra Gangi; James R Howe
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

Review 7.  Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Authors:  Abdul Saied; Steven C Katz; N Joseph Espat
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

Review 8.  [Oligometastasized stage IV colorectal cancer : Surgical resection and local ablative procedures].

Authors:  M Binnebösel; P Bruners; C D Klink; C Kuhl; U P Neumann
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

Review 9.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

10.  Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases.

Authors:  Andrew McKay; Katherine Fradette; Jeremy Lipschitz
Journal:  HPB Surg       Date:  2010-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.